Explore
Validate
Learn
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10138-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10138-1-AP, RRID:AB_2203686
- Product name
- HVEM/TNFRSF14 antibody
- Antibody type
- Polyclonal
- Description
- HVEM/TNFRSF14 antibody (Cat. #10138-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Aryl hydrocarbon receptor facilitates HSV-1 lytic infection by enhancing viral gene transcription and receptor expression.
FXR shapes an immunosuppressive microenvironment in PD-L1lo/- non-small cell lung cancer by upregulating HVEM.
Tumor Cell-Expressed Herpesvirus Entry Mediator Regulates Proliferation and Adaptive Immunity in Ovarian Cancer.
Increased expression of TNFRSF14 and LIGHT in biliary epithelial cells of patients with primary sclerosing cholangitis.
Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition.
Immune checkpoint molecule herpes virus entry mediator is overexpressed and associated with poor prognosis in human glioblastoma.
Characterization of herpes virus entry mediator as a factor linked to obesity.
Huang P, Pan X, Chen H, Lei M, Ma Y, Guo X, Xie J, Li J, Sun J, Hu Y, Shi J
Frontiers in cellular and infection microbiology 2025;15:1548038
Frontiers in cellular and infection microbiology 2025;15:1548038
FXR shapes an immunosuppressive microenvironment in PD-L1lo/- non-small cell lung cancer by upregulating HVEM.
Xu X, Shang B, Wu H, Jin X, Wang J, Li J, Li D, Liang B, Wang X, Su L, You W, Jiang S
JCI insight 2025 Sep 23;10(18)
JCI insight 2025 Sep 23;10(18)
Tumor Cell-Expressed Herpesvirus Entry Mediator Regulates Proliferation and Adaptive Immunity in Ovarian Cancer.
Lu Y, Zhang Y, Li W, Jiang H, Wang J, Guo X
Immunity, inflammation and disease 2025 Mar;13(3):e70175
Immunity, inflammation and disease 2025 Mar;13(3):e70175
Increased expression of TNFRSF14 and LIGHT in biliary epithelial cells of patients with primary sclerosing cholangitis.
Kanai S, Fujiwara H, Mizuno S, Kishikawa T, Nakatsuka T, Hamada T, Tanaka M, Arita J, Nakai Y, Isayama H, Kasuga M, Tateishi R, Tateishi K, Ushiku T, Hasegawa K, Koike K, Fujishiro M
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2024 Feb;56(2):305-311
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2024 Feb;56(2):305-311
Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition.
Xia L, Zheng Z, Liu JY, Chen YJ, Ding J, Hu GS, Hu YH, Liu S, Luo WX, Xia NS, Liu W
Cancer immunology research 2021 Jun;9(6):707-722
Cancer immunology research 2021 Jun;9(6):707-722
Immune checkpoint molecule herpes virus entry mediator is overexpressed and associated with poor prognosis in human glioblastoma.
Han MZ, Wang S, Zhao WB, Ni SL, Yang N, Kong Y, Huang B, Chen AJ, Li XG, Wang J, Wang DH
EBioMedicine 2019 May;43:159-170
EBioMedicine 2019 May;43:159-170
Characterization of herpes virus entry mediator as a factor linked to obesity.
Bassols J, Moreno JM, Ortega F, Ricart W, Fernandez-Real JM
Obesity (Silver Spring, Md.) 2010 Feb;18(2):239-46
Obesity (Silver Spring, Md.) 2010 Feb;18(2):239-46
No comments: Submit comment
No validations: Submit validation data